Accelerate Licensing & Co-Development in Asia: Providing Pharma De-Risked Assets to Fuel Pipelines Faster, & Biotech Access to International Partnerships & Capital

For ADCs, BsAbs, TCEs, TPD and RLT: The Hyper-Aligned Partnership Event Delivering Better Access to Global Big Pharma Seeking Innovation in Asia

With fast, cost-effective clinical infrastructure, generous government incentives, and simplified regulatory pathways, Asia’s biotech ecosystem has emerged as a global launchpad for innovation. Western pharma and biotech companies are increasingly turning to de-risked assets from Asia to supercharge their clinical pipelines and gain a competitive edge.

Already running in the US, the Targeted Therapies Partnering & Licensing Summit Asia is built to gather a regional, critical mass of ADC, Bispecific Antibody, T-Cell Engager, Targeted Protein Degradation, and Radiopharmaceutical platforms and pipelines, so that global multi-national (MNC) pharma can connect with biotech business development and discuss new licensing and co-development opportunities.

For NewCo, private and public biotech or small pharma, this accessible forum offers:

  • High seniority and quality of attendees across pharma and other biotech
  • Targeted focus, purpose-built format, and One-on-One Partnering portal allowing you to make meaningful connections easier and more efficient
  • Informative presentations and discussions nuanced to considerations for deal-making across targeted therapies

Global exposure, local advantage. Pharma can assess related programs back-to-back and biotech can meet multiple, international big pharma.

The focused niche really increased the impact for us overall. Thanks for including us in the program.

Executive Director, Business Development, Roche

Roche logo

It was stellar; I heard this sentiment echoed throughout. We appreciated the focused yet expansive discussions and talks in a more intimate setting, allowing for easier networking, too.

Executive Director, Business Development, BMS

BMS logo

I thought it was fantastic - operationally excellent and thoughtfully designed.

Executive Director, Business Development, Merck

Merck logo

It was a great group of high-quality companies/people in the perfect setting.

Executive Director, Business Development, J&J

J&J at Targeted Therapies Partnering & Licensing Summit Asia

I like the format. It meant the companies knew what Sanofi was looking for and made the 30-minute meetings very efficient. 

Executive Director, Business Development, Sanofi

Sanofi at Targeted Therapies Partnering & Licensing Summit Asia

Explore the Full Event Guide

  • 100% alignment across research focus, business needs and individual responsibilities to increase the efficiency and results of networking
  • Global pharma business development panel discussion to hear pharma’s wants and needs
  • Asia investors formal networking session to understand excitement around investing
  • Informal drinks and networking reception to connect with other attendees
  • Intersecting adjacent markets at the frontier of Asia deal-making, to learn from peers across related fields: ADCs, TPD, BsAbs, TCEs and RLTs
Brochure image for Targeted Therapies Licensing & Partnering Asia (1)

Statistics from US Summit’s in 2024 & 2025:

Since running related meetings in the US, there has been demand from pharma and Asia biotech to offer the same format in a more accessible location, to increase connection opportunities. We hope this forum in Tokyo will gather critical masses of both parties.

60+

Different organizations

70%

C-level from biotech

10+

Pharma representatives

40%

Acceptance rate of meeting requests

15

minute presentation opportunities

How is this Networking Format Delivered?

Day One Pharma Icebreaker Panel & Matchmaking
  1. Start the conference by understanding what MNCs are seeking to in-license or co-develop with the Pharma Icebreaker Panel Discussion, from differentiation that stimulates interest, to innovation that specifically aligns with their own strategies. Hear from all 9 Pharma External Innovation Leads from the US and Asia
  2. After the insights, introduce yourself to all pharma representatives during the Pharma Matchmaking Roundtables, to lay the groundwork for follow-up conversations
  3. During the rest of the conference, use private meetings through the One-on-One PartneringTM Portal to present your pitch deck and get dedicated feedback. An end-to-end format ensures you receive focused attention without the distraction of a larger, more crowded setting
Curated Insights

Focused & Relevant Content Across Panel Discussions 

Leverage insights from across adjacent markets, including ADCs, Targeted Antibodies, Protein Degradation, and Radioisotopes to drive innovation and successful partnerships. By uniting these fields in panel discussions, industry leaders can explore how advances in one area lead to success in others. This cross-pollination of ideas and technologies will help participants understand the synergistic relationships between these markets

Your Time to Shine

Short Company Presentations to Pitch to Pharma in Attendance

Register to present in one of the limited 15-minute presentation slots, to take advantage of the full engagement of pharma attending. Stir up interest in advance with complimentary branding on the website and host your logo at the event, alongside other innovators in the field

Attending Companies Include

J&J at Targeted Therapies Partnering & Licensing Summit Asia
Roche logo
AP Biosciences at Targeted Therapies Partnering & Licensing Summit Asia
Review the Program

Assess the speaking faculty, networking sessions, and biotech presenting slots by securing a copy of the full agenda.

Register to Join

Be part of this privileged forum bridging the gap between innovative R&D and partnership conversations. Secure a presentation opportunity whilst they remain and share your company description with us to advertise on this website.

Become a Founding Partner

If you’re a CRO, CDMO or other contract drug service looking for a differentiated and near exclusive opportunity to generate insights and intelligence into your target market, ensure you’re presented as a Founding Partner to associate your brand with the leading edge of these fields’ advancement.